These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8937317)

  • 1. The characterization of liver tumours by MRI.
    Robinson PJ
    Clin Radiol; 1996 Nov; 51(11):749-61. PubMed ID: 8937317
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characterization of hepatic neoplasms: contribution of magnetic resonance].
    Gualdi GF; Volpe A; Polettini E; Ceroni AM; Melone A; Casciani E
    Clin Ter; 1994 Jul; 145(7):53-63. PubMed ID: 7955951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic MR imaging of hepatic adenomas with pathologic correlation.
    Miyazaki T; Yamashita Y; Yamamoto H; Yoshimatsu S; Takahashi M; Ogawa M; Ishimaru Y
    Comput Med Imaging Graph; 1994; 18(5):373-80. PubMed ID: 7954314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
    Fowler KJ; Brown JJ; Narra VR
    Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of paediatric liver tumours with pathological correlation.
    Das CJ; Dhingra S; Gupta AK; Iyer V; Agarwala S
    Clin Radiol; 2009 Oct; 64(10):1015-25. PubMed ID: 19748008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver round foci: malignant or harmless?].
    Stiefelhagen P
    MMW Fortschr Med; 2004 Sep; 146(40):55-6. PubMed ID: 15529678
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic neoplasms: computed tomography and magnetic resonance features.
    Fulcher AS; Sterling RK
    J Clin Gastroenterol; 2002 Apr; 34(4):463-71. PubMed ID: 11907365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte-specific magnetic resonance imaging contrast agents.
    Fidler J; Hough D
    Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
    [No Abstract]   [Full Text] [Related]  

  • 9. Computed tomography and magnetic resonance imaging evaluation of liver cancer.
    Harisinghani MG; Hahn PF
    Gastroenterol Clin North Am; 2002 Sep; 31(3):759-76, vi. PubMed ID: 12481730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary liver neoplasms: MR imaging with pathologic correlation.
    Powers C; Ros PR; Stoupis C; Johnson WK; Segel KH
    Radiographics; 1994 May; 14(3):459-82. PubMed ID: 8066263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
    Vogl TJ; Hammerstingl R; Keck H; Felix R
    Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
    Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
    Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multidisciplinary management of gastrointestinal cancer. The diagnostic and therapeutic approach for primary solid liver tumours in adults.
    Verslype C; Libbrecht L
    Best Pract Res Clin Gastroenterol; 2007; 21(6):983-96. PubMed ID: 18070699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of benign liver lesions.
    Mathieu D; Caseiro-Alves F
    JBR-BTR; 2004; 87(2):76-83. PubMed ID: 15174807
    [No Abstract]   [Full Text] [Related]  

  • 17. Magnetic resonance imaging of hepatocellular carcinoma mimicking focal nodular hyperplasia: a potential pitfall in patients with cirrhosis?
    Rafaelian O; Coakley FV; Qayyum A; Breiman RS; Yeh BM; Joe BN; Westphalen AC; Feng S
    J Comput Assist Tomogr; 2006; 30(5):796-9. PubMed ID: 16954932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
    Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
    Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnetic resonance in the evaluation of tumors of the liver].
    Gualdi GF; Caterino M; Trasimeni G; Polettini E; Pingi A
    Clin Ter; 1988 Oct; 127(2):147-50. PubMed ID: 2852572
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.